1161931-95-8 Usage
Uses
Used in Pharmaceutical Synthesis:
(3R,4R)-4-benzylamino-3-hydroxy-4-piperidine-1-carboxylic acid tert-butyl ester is used as a building block for the synthesis of various pharmaceuticals and biologically active molecules. Its unique structure and reactivity make it a valuable component in creating new drugs with potential therapeutic applications.
Used in Drug Discovery Research:
In the field of drug discovery, (3R,4R)-4-benzylamino-3-hydroxy-4-piperidine-1-carboxylic acid tert-butyl ester serves as a key intermediate for developing novel compounds with specific biological activities. Its chiral nature allows for the exploration of different enantiomers, potentially leading to more effective and selective medications.
Used in Organic Synthesis:
(3R,4R)-4-benzylamino-3-hydroxy-4-piperidine-1-carboxylic acid tert-butyl ester is also utilized in organic synthesis, where its functional groups can be manipulated to create a wide range of chemical products. This versatility makes it an important compound for the development of new materials and chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 1161931-95-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,6,1,9,3 and 1 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1161931-95:
(9*1)+(8*1)+(7*6)+(6*1)+(5*9)+(4*3)+(3*1)+(2*9)+(1*5)=148
148 % 10 = 8
So 1161931-95-8 is a valid CAS Registry Number.
1161931-95-8Relevant articles and documents
MINERALOCORTICOID RECEPTOR ANTAGONISTS AND METHODS OF USE
-
Page/Page column 27-28, (2009/07/10)
The present invention provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly congestive heart failure, hypertension, diabetic nephropathy, or chronic kidney disease, comprising administering a compound of Formula (I), or a pharmaceutically acceptable salt thereof.
CHEMICAL COMPOUNDS
-
, (2010/02/15)
The use of a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein X1, X2, X3, X4, Ra, p, R1,Z,Y, R2, R3 and R4 are as d
